CJC1295/ Ipamorelin

This advanced peptide blend brings together two of the most studied growth hormone secretagogues—CJC-1295 without DAC (Mod GRF 1-29) and Ipamorelin—in a precise 1:1 ratio for a truly synergistic effect. Research suggests that when combined, these peptides may stimulate growth hormone release 3–5 times higher than either compound on its own.
Each vial contains 10 mg total (5 mg CJC-1295 + 5 mg Ipamorelin) of ultra-pure, lyophilized powder, designed for consistency, stability, and research precision.
Think of this blend as a perfectly synchronized performance. CJC-1295 sets the stage by extending the activity of the body’s natural growth hormone–releasing signals, while Ipamorelin delivers clean, powerful pulses that amplify the response. Together, they work in harmony—enhancing natural rhythms rather than disrupting them.
What makes this combination especially compelling is its balanced mechanism of action. CJC-1295 without DAC helps prolong endogenous GH signaling, while Ipamorelin selectively encourages the pituitary to release growth hormone without significantly influencing cortisol or prolactin. The result is a more natural, physiologically aligned secretion pattern that researchers are exploring for metabolic support, body composition research, and tissue recovery pathways.
Elegant, efficient, and intelligently designed—this blend stands out as one of the most sophisticated combinations in growth hormone research today.